• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大不列颠哥伦比亚省 2000 年至 2017 年人乳头瘤病毒免疫接种计划对肛门生殖器疣发病率的影响。

Impacts of Human Papillomavirus Immunization Programs on Rates of Anogenital Warts in British Columbia, Canada, 2000 to 2017.

机构信息

From the Faculty of Medicine, University of British Columbia.

BC Centre for Disease Control.

出版信息

Sex Transm Dis. 2020 Oct;47(10):691-697. doi: 10.1097/OLQ.0000000000001235.

DOI:10.1097/OLQ.0000000000001235
PMID:32649583
Abstract

BACKGROUND

In 2008, British Columbia (BC) implemented a school-based quadrivalent human papillomavirus (HPV-4) immunization program for girls born in 1994 or later. In 2015, an expanded clinic-based program included men who report sex with men (MSM) born in 1989 or later. To evaluate the impacts of HPV-4 programs on anogenital warts (AGWs), diagnosis rates were measured among women who report sex with men (WSM), men who report sex with women (MSW), and MSM.

METHODS

Diagnoses of AGW were ascertained from 16 sexually transmitted infection clinics. Rates were calculated as new AGW diagnoses over person-years (py) at risk and stratified by age group, calendar period, and birth cohort. Adjusted relative rates (aRR) were estimated using multivariable Poisson regression.

RESULTS

There were 204,832 clinic visits by 85,158 individuals: 28,366 (33%) WSM, 35,688 (42%) MSW, and 14,534 (17%) MSM. After adjusting for age and period, AGW rates in the 1994-1996 birth cohort decreased by 56% overall (1.21 vs. 2.72 cases/100 py; aRR, 0.44; 95% confidence interval [CI], 0.34-0.59), 65% among WSM (0.97 vs. 2.77 cases/100 py; aRR, 0.35; 95% CI, 0.22-0.57), 58% among MSW (1.60 vs. 3.78 cases/100 py; aRR, 0.42; 95% CI, 0.28-0.65), and 41% among MSM (1.14 vs. 1.19 cases/100 py; aRR, 0.59; 95% CI, 0.38-0.91) versus the 1991-1993 birth cohort.

CONCLUSIONS

The HPV-4 programs had significant impacts on lowering AGW rates in BC. The greatest decrease was among WSM eligible for the school-based program, followed by birth cohorts of men who likely have sex with HPV-4 eligible women. The smallest decrease among MSM may reflect the later introduction of the clinic-based program.

摘要

背景

2008 年,不列颠哥伦比亚省(BC)为 1994 年或以后出生的女孩实施了基于学校的四价人乳头瘤病毒(HPV-4)免疫接种计划。2015 年,扩大的基于诊所的计划包括报告与男性发生性行为(MSM)的 1989 年或以后出生的男性。为了评估 HPV-4 计划对肛门生殖器疣(AGW)的影响,在报告与男性发生性行为(WSM)的女性、报告与女性发生性行为(MSW)的男性和 MSM 中测量了 AGW 的诊断率。

方法

通过 16 个性传播感染诊所确定 AGW 的诊断。根据年龄组、日历期和出生队列,以新的 AGW 诊断数除以风险人年(py)计算发病率。使用多变量泊松回归估计调整后的相对发病率(aRR)。

结果

共有 85158 人进行了 204832 次就诊:28366 人(33%)为 WSM,35688 人(42%)为 MSW,14534 人(17%)为 MSM。在调整年龄和时期后,1994-1996 年出生队列的 AGW 发病率总体下降了 56%(1.21 与 2.72 例/100 py;aRR,0.44;95%置信区间[CI],0.34-0.59),WSM 下降了 65%(0.97 与 2.77 例/100 py;aRR,0.35;95% CI,0.22-0.57),MSW 下降了 58%(1.60 与 3.78 例/100 py;aRR,0.42;95% CI,0.28-0.65),MSM 下降了 41%(1.14 与 1.19 例/100 py;aRR,0.59;95% CI,0.38-0.91)与 1991-1993 年出生队列相比。

结论

HPV-4 计划对降低卑诗省的 AGW 发病率产生了重大影响。降幅最大的是符合学校计划条件的 WSM,其次是可能与 HPV-4 合格女性发生性行为的男性的出生队列。MSM 中降幅最小可能反映了诊所计划的推出较晚。

相似文献

1
Impacts of Human Papillomavirus Immunization Programs on Rates of Anogenital Warts in British Columbia, Canada, 2000 to 2017.加拿大不列颠哥伦比亚省 2000 年至 2017 年人乳头瘤病毒免疫接种计划对肛门生殖器疣发病率的影响。
Sex Transm Dis. 2020 Oct;47(10):691-697. doi: 10.1097/OLQ.0000000000001235.
2
Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.自 2012 年在英格兰使用四价 HPV 疫苗以来,肛门生殖器疣诊断病例的减少:截至 2017 年底的数据。
Sex Transm Infect. 2019 Aug;95(5):368-373. doi: 10.1136/sextrans-2018-053751. Epub 2019 Feb 5.
3
Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.安大略省人乳头瘤病毒(HPV)疫苗接种计划对肛门生殖器疣(AGW)的早期影响:基于人群的评估。
Vaccine. 2016 Sep 7;34(39):4678-4683. doi: 10.1016/j.vaccine.2016.08.020. Epub 2016 Aug 12.
4
Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.西班牙加泰罗尼亚地区实施单一年龄组人乳头瘤病毒疫苗接种策略的影响:对男女肛门生殖器疣的基于人群的分析。
Prev Med. 2020 Sep;138:106166. doi: 10.1016/j.ypmed.2020.106166. Epub 2020 Jun 18.
5
The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.加拿大魁北克省人乳头瘤病毒疫苗接种对肛门生殖器疣的早期影响。
J Med Virol. 2018 Mar;90(3):592-598. doi: 10.1002/jmv.24968. Epub 2017 Nov 11.
6
Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.二价人乳头瘤病毒 16/18 疫苗接种对荷兰初级保健患者肛门生殖器疣的部分保护作用。
Clin Infect Dis. 2021 Jul 15;73(2):291-297. doi: 10.1093/cid/ciaa582.
7
Longitudinal uptake of the human papillomavirus vaccine among gay, bisexual and other men who have sex with men in British Columbia, Canada 2012-2019.2012-2019 年加拿大不列颠哥伦比亚省男同性恋、双性恋和其他与男性发生性关系的男性中人类乳头瘤病毒疫苗的纵向接种情况。
Sex Transm Infect. 2022 Jun;98(4):302-306. doi: 10.1136/sextrans-2020-054871. Epub 2021 Aug 16.
8
Effectiveness and cost-effectiveness of human papillomavirus vaccination strategies among men who have sex with men in China: a modeling study.在中国男男性行为者中,人乳头瘤病毒疫苗接种策略的有效性和成本效益:一项建模研究。
Front Immunol. 2023 Jun 22;14:1197191. doi: 10.3389/fimmu.2023.1197191. eCollection 2023.
9
Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals.四价人乳头瘤病毒疫苗预防肛门生殖器疣的效果:基于登记的 220 万人研究。
Vaccine. 2023 Aug 23;41(37):5469-5476. doi: 10.1016/j.vaccine.2023.07.031. Epub 2023 Jul 27.
10
Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics-Sexually Transmitted Disease Surveillance Network, United States, 2010-2016.性传播疾病监测网络:2010-2016 年美国性传播疾病门诊患者肛门生殖器疣流行趋势
J Infect Dis. 2019 Apr 16;219(9):1389-1397. doi: 10.1093/infdis/jiy684.

引用本文的文献

1
Human Papillomavirus Vaccine Impact and Effectiveness in Six High-Risk Populations: A Systematic Literature Review.人乳头瘤病毒疫苗对六个高危人群的影响及有效性:一项系统文献综述
Vaccines (Basel). 2022 Sep 16;10(9):1543. doi: 10.3390/vaccines10091543.
2
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018.人乳头瘤病毒疫苗在美国引入后 12 年的影响和效果,2003 至 2018 年。
Ann Intern Med. 2022 Jul;175(7):918-926. doi: 10.7326/M21-3798. Epub 2022 May 17.
3
Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States.
美国男同性恋者、双性恋者和其他与男性发生性关系者以及跨性别女性的人乳头瘤病毒(HPV)负担和 HPV 疫苗接种综述。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2016007. doi: 10.1080/21645515.2021.2016007. Epub 2022 Mar 16.